Publications by authors named "S Zechel"

This current study focusses on the investigation of the self-healing abilities of metallopolymers containing different kinds of metal complexes, which were processed by direct digital light processing (DLP) based three-dimensional (3D) printing. For this purpose, 2‑phenoxyethyl acrylate is mixed with ligand-containing monomers either based on triphenylmethyl(trt)-histidine or terpyridine, respectively. Either zinc(II) or nickel(II) salts are successfully applied for a complexation of the ligand monomers in solution and, subsequently, photopolymerization is performed.

View Article and Find Full Text PDF

Background: Intracerebral schwannomas are rare tumors resembling their peripheral nerve sheath counterparts but localized in the CNS. They are not classified as a separate tumor type in the 2021 WHO classification. This study aimed to compile and characterize these rare neoplasms morphologically and molecularly.

View Article and Find Full Text PDF

The construction of ultrathin membranes from linearly aligned π-electron systems is advantageous for targeted energy, charge, or mass transfer. The Langmuir-Blodgett (LB) technique enables the creation of such membranes, especially with amphiphilic π-electron systems. However, these systems often aggregate, forming rigid Langmuir monolayers with defects or holes.

View Article and Find Full Text PDF

Paper used for packaging applications is often coated with thin polymer coatings to improve the properties, like printability and barrier properties, respectively. Today, these coatings are still often based on petroleum-based polymers. In this study, the fabrication of biobased thin film coatings is described.

View Article and Find Full Text PDF

Purpose: Improved survival rates have been observed in castration-resistant prostate cancer (CRPC) due to advancements in treatment options. However, individuals with brain metastases still have limited therapeutic options and an unfavorable prognosis. Therefore, there is an urgent need to explore new therapeutic avenues, such as antibody-drug conjugates (ADCs), which have demonstrated significant clinical activity against active brain metastases in solid tumors.

View Article and Find Full Text PDF